Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)

CUSIP: 925050106

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, nominal value 0.05 GBP per share
Shares outstanding
84,213,667
Total 13F shares
75,959,176
Share change
+3,589,807
Total reported value
$7,178,711,698
Put/Call ratio
348%
Price per share
$94.58
Number of holders
291
Value change
+$377,068,942
Number of buys
148
Number of sells
142

Quarterly Holders Quick Answers

What is CUSIP 925050106?
CUSIP 925050106 identifies VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q2 2025

As of 30 Jun 2025, Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by 291 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,959,176 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, Darwin Global Management, Ltd., Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, EVENTIDE ASSET MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, NEA Management Company, LLC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, and FARALLON CAPITAL MANAGEMENT LLC. This page lists 292 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
258
Q2 2025 holders
291
Holder diff
33
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .